Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2025 11:45 ET | Source: Cyber A.I. Group, Inc.

Cyber A.I. Group Names Jessica L. Walters President

CyberAI Group names Jessica Walters President to lead AI-driven cybersecurity growth, M&A integration, and IPO readiness.
September 12, 2025 10:30 ET | Source: Precedence Research

Targeted Therapy Market Size Projects USD 155.82 Billion by 2034

Ottawa, Sept. 12, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister firm of Precedence Research, the global targeted therapy market size was valued at USD 80.18 billion...
September 12, 2025 08:45 ET | Source: 24/7 Market News and Kraig Labs

24/7 Market News: Kraig Labs Positioned at the Forefront of the Next-Gen Materials Revolution

Kraig Labs (OTCQB: KBLB), the global spider silk leader, is uniquely positioned to capitalize on the Wearable Devices and fashion markets
September 12, 2025 08:30 ET | Source: Prenetics Global Limited

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End

1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 –...
September 11, 2025 16:01 ET | Source: Actuate Therapeutics

Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on...
September 11, 2025 16:00 ET | Source: Recludix Pharma, Inc.

Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum

SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D.,...
September 11, 2025 10:26 ET | Source: Research and Markets

Biotech, Pharmaceuticals & Genetics Industry Almanac 2026: Market Research, Statistics, Trends and Leading Companies

Dublin, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The "Biotech, Pharmaceuticals & Genetics Industry Almanac 2026: Market Research, Statistics, Trends and Leading Companies" book from Plunkett Research...
September 11, 2025 09:27 ET | Source: MAIA Biotechnology, Inc.

MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted...
September 11, 2025 08:00 ET | Source: GLOBAL MOFY AI LIMITED

Global Mofy AI Launches New Website Domain to Strengthen Global AI Brand Identity

BEIJING, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content...
September 11, 2025 08:00 ET | Source: Vera Bradley, Inc.

Vera Bradley Announces Second Quarter Fiscal Year 2026 Results

FORT WAYNE, Ind., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced its financial results for the second quarter of the fiscal year ending January...